Description: We are a healthcare consultancy conceiving and rolling out Global and French-setting applied Market Access and Pricing solutions for health technologies.
We are a healthcare consultancy conceiving and rolling out Global and French-setting applied Market Access and Pricing solutions for health technologies. We intervene at all lifecycle stages from earliest R&D stage to post-launch for defining and achieving rewarding market conditions.
Strategic Access Road Map Access Conditions and competitive landscape scanning, benchmarking – Target Product Profile definition Asset profiling (endpoint selection, effectiveness extrapolation, biomarkers, patient subset…) – Value development plans Clinical and economic value pillar identification, value de-risking Plan (incl. HEOR plan, ATC code..), Payer Evidence Set, Value Dossiers – Pricing Price anchoring, Pricing strategies, new Pricing models – Early dialogues With HTA bodies at EU & French levels –
Early & Accelerated Access programs – Late dialogues With HTA body at the EU level – HTA applications At the French & EU levels – HTA body hearing Preparation & attendance – Pricing Policy definition, negotiation support & contracting insights